With this guideline, the World Gastroenterology Organisation (WGO) is aiming to guide
health providers in the best management of irritable bowel disease (IBS) through a concise …

Irritable bowel syndrome (IBS) is common in western Europe and North America, and many
aspects of its epidemiology, risk factors, and natural history have been described in these …

INTRODUCTION Definition: IBS is a functional bowel disorder in which abdominal pain or
discomfort is associated with defecation and/or a change in bowel habit. Sensations of …

Although irritable bowel syndrome (IBS) is common worldwide, there is uncertainty
regarding similarities and differences in geographical regions and cultural groups. For …

Background Effective management of irritable bowel syndrome (IBS), a common functional
gastrointestinal disorder, can be challenging for physicians because of the lack of simple …

Irritable bowel syndrome affects approximately 10–15% of the European population,
although prevalence rates vary depending on the classification used and the country …

Irritable bowel syndrome (IBS), a chronic gastrointestinal disorder, affects from 3–20% of the
US population, depending on sociocultural and comorbid factors. IBS is characterized by a …

These guidelines constitute an update of the previous “Recommendations on the
management of irritable bowel syndrome” issued in 2008. They have been developed by a …

Irritable bowel syndrome (IBS) is a chronic and debilitating functional gastrointestinal
disorder that affects 9%-23% of the population across the world. The percentage of patients …

Background: IBS affects 5–11% of the population of most countries. Prevalence peaks in the
third and fourth decades, with a female predominance. Aim: To provide a guide for the …